Details
- session_id
- sess_SDA-BIOMNI-CLINICAL-b7a71edd
- round_number
- 2
- agent_persona
- persona-skeptic
- agent_backend
- mini-max
- action
- critique
- tokens_used
- 101
Raw fields (1)
- content
# Critical Evaluation of AD Clinical Trial Landscape Hypotheses --- ## Hypothesis 1: Amyloid-Centric Pipeline Distortion ### Weaknesses and Challenges 1. **Causal claim is unestablished.** The hypothesis asserts crowding out, but correlation between amyloid investment and lack of downstream efficacy does not prove causation. Other mechanisms (tau, neuroinflammation) have been tried and failed for